Blood-Clotting showdown: which device best guides bleeding care in High-Risk patients?

NCT ID NCT06635564

First seen Jul 15, 2026 · Last updated Jul 16, 2026 · Updated 1 time

Summary

This study compares three devices that measure how well blood clots — ClotPro, ROTEM, and TEG — in patients undergoing liver surgery, neurosurgery, or cesarean section. The goal is to see how closely the results from these devices agree with each other. The findings may help doctors choose the best tool for personalized bleeding management, but the test results will not be used to guide treatment during this study.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this study could help identify which device provides the most accurate and reliable blood-clotting information, potentially improving bleeding management in high-risk surgeries and childbirth.
What could go wrong
This is an observational comparison study, not a treatment trial. The results may not directly change patient care, and the devices may show similar performance, limiting the impact.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLEEDING DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Medical University of Vienna

    Vienna, Austria, 1090, Austria

More trials for these conditions

Other studies related to the condition(s) this trial covers.